FibroGen Inc (FGEN) — Capital Reinvestment Ratio
Latest as of June 2025:
0.00x
FibroGen Inc (FGEN) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($12.68 Million) in capital expenditures ($13.00K). See FibroGen Inc (FGEN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$12.68 Million
USD
Capital Expenditures
$13.00K
USD
Data as of
Jun 2025
Most recent filing
FibroGen Inc Capital Reinvestment Ratio (2013–2020)
This chart tracks FibroGen Inc's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for FibroGen Inc (2013–2020)
Year-by-year Capital Reinvestment Ratio for FibroGen Inc from 2013 to 2020. For live market cap and broader valuation context, see how much is FibroGen Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $81.60 Million | $3.99 Million | ▼ -72.2% |
| 2016 | 0.18x | $7.11 Million | $1.25 Million | ▼ -51.4% |
| 2014 | 0.36x | $22.41 Million | $8.12 Million | ▲ +37.9% |
| 2013 | 0.26x | $25.92 Million | $6.81 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow